Interestingly, reduced recruitment of neutrophils was observed in the neutrophil-like cell-membrane-coated mesoporous Prussian blue nanozyme (MPBzyme@NCM) treated tMCAO/stroke mice at day 5 after stroke, as indicated by Western blotting analyses of myeloperoxidase, a marker for neutrophils. Here, MPO is linked to stroke disorder.